Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Centruroides immune Fab (equine) - Instituto Bioclon/Rare Disease Therapeutics

Drug Profile

Centruroides immune Fab (equine) - Instituto Bioclon/Rare Disease Therapeutics

Alternative Names: Anascorp; Scorpion immune Fab (equine)

Latest Information Update: 18 Mar 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Instituto Bioclon
  • Developer Instituto Bioclon; Rare Disease Therapeutics
  • Class Antibodies; Antivenins; Fab fragments
  • Mechanism of Action Scorpion venom inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Scorpion venom poisoning
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Scorpion venom poisoning

Most Recent Events

  • 03 Aug 2011 Registered for Scorpion venom poisoning in USA (IV)
  • 03 Aug 2011 Efficacy and adverse events data from a clinical trial in Scorpion venom poisoning released by the US FDA
  • 24 Aug 2005 Phase-II clinical trials in Scorpion venom poisoning in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top